{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-053607","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.524779+00:00","generated_at":"2026-05-19T10:35:08.481992+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Citius Pharma closes $6M registered direct offering with warrants for up to $9.8M additional proceeds","bullets":["Gross proceeds of $6M from sale of 4.92M shares/pre-funded warrants at $1.22 per share.","Short-term warrants to purchase up to 9.84M shares at $1.00; expire 24 months from issuance.","Net proceeds ~$5.455M after fees; used for LYMPHIR commercial launch and corporate purposes.","H.C. Wainwright placement agent; 7% cash fee plus placement agent warrants at $1.525 exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-053607","json":"https://secwatch.observer/filing/0001213900-25-053607.json","markdown":"https://secwatch.observer/filing/0001213900-25-053607.md","text":"https://secwatch.observer/filing/0001213900-25-053607.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025053607/0001213900-25-053607-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025053607/ea0245241-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:35:08.481992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}